Laura Pierson | IR |
Lawrence Mehren | President & CEO |
Steve Reichling | CFO |
Brian Weinstein | William Blair |
Rachel Vatnsdal | Piper Jaffray |
Good afternoon, and welcome to the Accelerate Diagnostics First Quarter 2019 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Laura Pierson. Please go ahead.
Before we begin, it is important to share that information presented during this call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.